Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918136 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Adipose-Derived Stem Cell Injection Partial Thickness Rotator Cuff Tears
A NA study, sponsored by InGeneron.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02918136: Completed NA study, sponsored by InGeneron.
NCT02918136 is a NA study that has completed, run by InGeneron. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02918136, a NA study, has completed, sponsored by InGeneron.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a prospective, randomized, multi-site, safety and efficacy study in subjects with rotator cuff injuries. Patients will fall into two categories: treatment group (12 subjects) and non-treatment or control group (six subjects). The treatment group will undergo a small liposuction procedure and receive rotator cuff repair treatment with an ultrasound-guided injection of 5cc adipose-derived stem cells (ADSCs) into the point of injury. The control group will receive a 5cc cortisone injection into the point of injury
Interventions
- BIOLOGICAL Adipose derived regenerative cells
- DRUG Cortisone Injectable
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-12-13 |
| Phase | NA |
What the finished NCT02918136 record still lists
NCT02918136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Adipose derived regenerative cells is the first listed.
NCT02918136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02918136 about?
NCT02918136 is a clinical study titled "Safety and Efficacy Adipose-Derived Stem Cell Injection Partial Thickness Rotator Cuff Tears". This is a prospective, randomized, multi-site, safety and efficacy study in subjects with rotator cuff injuries. Patients will fall into two categories: treatment group (12 subjects) and non-treatment or control group (six subjects). The treatment group will undergo a small liposuction procedure an...
What is the current status of trial NCT02918136?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2016-12. Estimated completion is 2018-12-13.
What interventions are being tested in trial NCT02918136?
The interventions under investigation include: Adipose derived regenerative cells (BIOLOGICAL), Cortisone Injectable (DRUG).
Who is sponsoring clinical trial NCT02918136?
This trial is sponsored by InGeneron, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02918136's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia